Eribulin improved overall survival in patients with HER-2 negative metastatic breast cancer: Comparison to bevacizumab plus paclitaxel. This is an ASCO Meeting Abstract from the 2016 ASCO Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results